Back to Search
SUCHEE MADHUSUDAN, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1841477346IndividualAccepts Medicare
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
203399(NY)
Education
OTHER
Research & Publications (20)
Independent regulation of H-NS-mediated silencing of the bgl operon at two levels: upstream by BglJ and LeuO and downstream by DnaKJ.
PMID 16207917·Microbiology (Reading)·2005
8-other
Regulation of the yjjQ-bglJ operon, encoding LuxR-type transcription factors, and the divergent yjjP gene by H-NS and LeuO.
PMID 18055596·J Bacteriol·2008
8-other
Enhancement of bioavailability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques.
PMID 17867556·Pharmazie·2007
7-preclinical
Cancer pharmacogenomics: role of DNA repair genetic polymorphisms in individualizing cancer therapy.
PMID 18078354·Mol Diagn Ther·2007
6-review
Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.
PMID 17707593·Cancer Treat Rev·2007
6-review
Tandem mass spectra of transition-metal ion adducts of glycosyl dithioacetals; distinction among stereoisomers.
PMID 15655791·Rapid Commun Mass Spectrom·2005
8-other
Effect of metal cationization on the tandem mass spectra of glycosyl dithioacetals.
PMID 15584006·J Mass Spectrom·2005
8-other
Cyclodextrin complexes of valdecoxib: properties and anti-inflammatory activity in rat.
PMID 15848054·Eur J Pharm Biopharm·2005
7-preclinical
The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer.
PMID 16298073·Cancer Treat Rev·2005
6-review
DNA repair inhibition: a selective tumour targeting strategy.
PMID 16214418·Trends Mol Med·2005
6-review
Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer.
PMID 16135466·J Clin Oncol·2005
3-trial
Isolation of a small molecule inhibitor of DNA base excision repair.
PMID 16113242·Nucleic Acids Res·2005
8-other
Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer.
PMID 15956976·Br J Cancer·2005
3-trial
Direct one-pot conversion of acylated carbohydrates into their alkylated derivatives under heterogeneous reaction conditions using solid NaOH and a phase transfer catalyst.
PMID 15854608·Carbohydr Res·2005
8-other
Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma.
PMID 15746054·Clin Cancer Res·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 5 locations total
- Address
- 368 Broadway
Kingston, NY 12401 - Phone
- (845) 331-3131
Locations (5)
Quick Facts
- NPI
- 1841477346
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 5
- Publications
- 20
Are you this provider?
Claim Your Profile